Nuvation Bio Inc.
Nuvation Bio Inc. (NUVB) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
nuvb · stock forecast · 9 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 9 Wall Street analysts in the past 3 months
Buy
9 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$17.00
Consensus
$13.00
+168.9% upside
Low
$10.00
Median: $12.5 · Last Close: $4.83
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$13.00
168.9% upside
High Target
$17
251.6%
Low Target
$10
106.8%
Current Price
$4.83
as of today
Based on analyst price targets, the NUVB stock price prediction for the next 12 months ranges from $10 to $17. The consensus NUVB price forecast of $13.00 implies 168.9% upside from the current price of $4.83.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $4.95 | ↑ 2.43% |
1-day model range: $4.92–$4.99. Peak: $4.99 (+2.43%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · NUVB · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-05 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-05 | Wedbush | Maintains | Outperform→Outperform |
| 2026-05-05 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-04-16 | Wedbush | Maintains | Outperform→Outperform |
| 2026-04-02 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-27 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-03 | UBS | Maintains | Neutral→Neutral |
| 2026-03-03 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-02-10 | Wedbush | Maintains | Outperform→Outperform |
| 2026-01-21 | RBC Capital | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Nuvation Bio Inc. (NUVB) stock. Of the recent 55 rating actions, 2 were upgrades and 3 were downgrades. 9 analysts currently cover NUVB.
Analyst Recommendation Trends
NUVB analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 3 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$202M
↓ 47.7% YoY
Revenue Next Year
$290M
↑ 43.1% YoY
EPS This Year
$-0.36
EPS Next Year
$-0.26
↓ 26.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast NUVB EPS of $-0.36 for the current fiscal year, based on estimates from 4 analysts. The NUVB revenue forecast is $202M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The NUVB stock forecast is supported by two independent data sources: analyst consensus ratings from 9 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus NUVB price target is $13.00 (+168.9% upside), with an analyst consensus of Buy.
The NUVB short-term stock prediction for tomorrow is $4.95 (+2.43%).
Nuvation Bio Inc. trades on NYSE under the ticker NUVB. The NUVB stock outlook for 2027 is broadly positive, supported by a Buy consensus among 78% of covering analysts.
Frequently asked questions
NUVB forecast · 8 questionsAccording to 9 Wall Street analysts, the average 12-month NUVB price target is $13.00, with a high forecast of $17.00 and a low of $10.00. The median price target is shown in the chart above when available. This implies +168.9% potential upside from the current price of $4.83.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.